AU2001292499A1 - 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain - Google Patents
7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of painInfo
- Publication number
- AU2001292499A1 AU2001292499A1 AU2001292499A AU9249901A AU2001292499A1 AU 2001292499 A1 AU2001292499 A1 AU 2001292499A1 AU 2001292499 A AU2001292499 A AU 2001292499A AU 9249901 A AU9249901 A AU 9249901A AU 2001292499 A1 AU2001292499 A1 AU 2001292499A1
- Authority
- AU
- Australia
- Prior art keywords
- pain
- tetrahydropyridazino
- pyridylethyl
- dione
- quinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HGYJAMYBDZZQQF-UHFFFAOYSA-N 7-chloro-2-(2-pyridin-2-ylethyl)-3,5-dihydropyridazino[4,5-b]quinoline-1,4,10-trione Chemical compound C=1C(Cl)=CC=C(C2=O)C=1NC(C(N1)=O)=C2C(=O)N1CCC1=CC=CC=N1 HGYJAMYBDZZQQF-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23663000P | 2000-09-29 | 2000-09-29 | |
| US60236630 | 2000-09-29 | ||
| PCT/SE2001/002125 WO2002026740A1 (fr) | 2000-09-29 | 2001-09-28 | 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione et son utilisation pour le traitement de la douleur |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001292499A1 true AU2001292499A1 (en) | 2002-04-08 |
Family
ID=22890309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001292499A Abandoned AU2001292499A1 (en) | 2000-09-29 | 2001-09-28 | 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6933297B2 (fr) |
| EP (1) | EP1325003B1 (fr) |
| JP (1) | JP2004509964A (fr) |
| AT (1) | ATE334982T1 (fr) |
| AU (1) | AU2001292499A1 (fr) |
| DE (1) | DE60121978D1 (fr) |
| WO (1) | WO2002026740A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6946463B2 (en) * | 2000-09-29 | 2005-09-20 | Astrazeneca Ab | 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| DE112005001286A5 (de) * | 2004-06-09 | 2007-05-24 | Abb Technology Ag | Gasisolierte Schaltanlage mit ein Sichtfenster zur optischen Erfassung die Schaltstellung der Schaltkontakten |
| RU2490253C2 (ru) | 2007-05-29 | 2013-08-20 | Интрексон Корпорейшн | Хиральные диацилгидразиновые лиганды для модуляции экспрессии экзогенных генов с помощью экдизон-рецепторного комплекса |
| RU2711968C1 (ru) * | 2018-11-22 | 2020-01-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский национальный исследовательский политехнический университет" | Анальгезирующее средство |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111266A (en) | 1993-10-22 | 2002-03-10 | Zeneca Ltd | 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| GB9507318D0 (en) | 1995-04-07 | 1995-05-31 | Zeneca Ltd | Alpha substituted pyridazino quinoline compounds |
| WO2001047524A1 (fr) * | 1999-12-23 | 2001-07-05 | Astrazeneca Ab | Methode et composition pour traiter la douleur |
| US20030153571A1 (en) * | 1999-12-23 | 2003-08-14 | Brown Dean Gordon | Method and composition for the treatment of pain |
| US6946463B2 (en) * | 2000-09-29 | 2005-09-20 | Astrazeneca Ab | 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
-
2001
- 2001-09-28 US US10/381,922 patent/US6933297B2/en not_active Expired - Fee Related
- 2001-09-28 DE DE60121978T patent/DE60121978D1/de not_active Expired - Lifetime
- 2001-09-28 WO PCT/SE2001/002125 patent/WO2002026740A1/fr not_active Ceased
- 2001-09-28 JP JP2002531124A patent/JP2004509964A/ja active Pending
- 2001-09-28 EP EP01972861A patent/EP1325003B1/fr not_active Expired - Lifetime
- 2001-09-28 AT AT01972861T patent/ATE334982T1/de not_active IP Right Cessation
- 2001-09-28 AU AU2001292499A patent/AU2001292499A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002026740A1 (fr) | 2002-04-04 |
| US6933297B2 (en) | 2005-08-23 |
| EP1325003B1 (fr) | 2006-08-02 |
| JP2004509964A (ja) | 2004-04-02 |
| EP1325003A1 (fr) | 2003-07-09 |
| US20040053930A1 (en) | 2004-03-18 |
| ATE334982T1 (de) | 2006-08-15 |
| DE60121978D1 (de) | 2006-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20053602B (en) | Aripiprazole for Oral Administration | |
| HUP0100437A2 (hu) | Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására | |
| CZ309247B6 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| AU7031500A (en) | Therapeutic quinazoline compounds | |
| BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| WO1992019617A3 (fr) | Composes de dibenzoxazepine substituee, compositions pharmaceutiques et procedes d'utilisation | |
| HUP0102728A2 (hu) | Módszerek és transzdermális készítmények fájdalom csillapítására | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| GEP20063895B (en) | Platinum derivative pharmaceutical formulations | |
| PT840601E (pt) | Thip para o tratamento de desordens do sono | |
| AU3850600A (en) | Dalda analogs and their use | |
| GEP20022801B (en) | Pyridazino [4,5-B]-Quinoline 5-Oxide Derivatives, Their Preparation and Their Use as Glycine Antagonists | |
| MY137752A (en) | Medicament for treating aseptic inflammations containing anemonin as effective component | |
| GB9907571D0 (en) | Compounds | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| AU2001292499A1 (en) | 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| ATE216891T1 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| BR9908838A (pt) | Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite | |
| BG105434A (en) | Sertraline oral concentrate | |
| WO2001068076A8 (fr) | Enantiomere en d de la dfmo et ses procedes d'utilisation | |
| MY133596A (en) | Compound and method for the treatment of pain |